189 related articles for article (PubMed ID: 33417276)
21. Liver-specific insulin receptor isoform A expression enhances hepatic glucose uptake and ameliorates liver steatosis in a mouse model of diet-induced obesity.
Lopez-Pastor AR; Gomez-Hernandez A; Diaz-Castroverde S; Gonzalez-Aseguinolaza G; Gonzalez-Rodriguez A; Garcia G; Fernandez S; Escribano O; Benito M
Dis Model Mech; 2019 Feb; 12(2):. PubMed ID: 30642871
[TBL] [Abstract][Full Text] [Related]
22. Liver sympathetic denervation reverses obesity-induced hepatic steatosis.
Hurr C; Simonyan H; Morgan DA; Rahmouni K; Young CN
J Physiol; 2019 Sep; 597(17):4565-4580. PubMed ID: 31278754
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance.
Lee HY; Birkenfeld AL; Jornayvaz FR; Jurczak MJ; Kanda S; Popov V; Frederick DW; Zhang D; Guigni B; Bharadwaj KG; Choi CS; Goldberg IJ; Park JH; Petersen KF; Samuel VT; Shulman GI
Hepatology; 2011 Nov; 54(5):1650-60. PubMed ID: 21793029
[TBL] [Abstract][Full Text] [Related]
24. Gracilaria chorda subcritical water ameliorates hepatic lipid accumulation and regulates glucose homeostasis in a hepatic steatosis cell model and obese C57BL/6J mice.
Thakuri LS; Park CM; Kim HA; Kim HJ; Park JW; Park JC; Rhyu DY
J Ethnopharmacol; 2024 Feb; 320():117395. PubMed ID: 37952731
[TBL] [Abstract][Full Text] [Related]
25. Hepatic CREBZF couples insulin to lipogenesis by inhibiting insig activity and contributes to hepatic steatosis in diet-induced insulin-resistant mice.
Zhang F; Hu Z; Li G; Huo S; Ma F; Cui A; Xue Y; Han Y; Gong Q; Gao J; Bian H; Meng Z; Wu H; Long G; Tan Y; Zhang Y; Lin X; Gao X; Xu A; Li Y
Hepatology; 2018 Oct; 68(4):1361-1375. PubMed ID: 29637572
[TBL] [Abstract][Full Text] [Related]
26. Dysregulation of microRNA-125a contributes to obesity-associated insulin resistance and dysregulates lipid metabolism in mice.
Liu R; Wang M; Li E; Yang Y; Li J; Chen S; Shen WJ; Azhar S; Guo Z; Hu Z
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 May; 1865(5):158640. PubMed ID: 31988048
[TBL] [Abstract][Full Text] [Related]
27. Pathophysiological importance of bile cholesterol reabsorption: hepatic NPC1L1-exacerbated steatosis and decreasing VLDL-TG secretion in mice fed a high-fat diet.
Toyoda Y; Takada T; Yamanashi Y; Suzuki H
Lipids Health Dis; 2019 Dec; 18(1):234. PubMed ID: 31883528
[TBL] [Abstract][Full Text] [Related]
28. Nutrigenomics of high fat diet induced obesity in mice suggests relationships between susceptibility to fatty liver disease and the proteasome.
Waller-Evans H; Hue C; Fearnside J; Rothwell AR; Lockstone HE; Caldérari S; Wilder SP; Cazier JB; Scott J; Gauguier D
PLoS One; 2013; 8(12):e82825. PubMed ID: 24324835
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia-inducible factor prolyl hydroxylase 1 (PHD1) deficiency promotes hepatic steatosis and liver-specific insulin resistance in mice.
Thomas A; Belaidi E; Aron-Wisnewsky J; van der Zon GC; Levy P; Clement K; Pepin JL; Godin-Ribuot D; Guigas B
Sci Rep; 2016 Apr; 6():24618. PubMed ID: 27094951
[TBL] [Abstract][Full Text] [Related]
30. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
[TBL] [Abstract][Full Text] [Related]
31. Long-term adaptation of global transcription and metabolism in the liver of high-fat diet-fed C57BL/6J mice.
Do GM; Oh HY; Kwon EY; Cho YY; Shin SK; Park HJ; Jeon SM; Kim E; Hur CG; Park TS; Sung MK; McGregor RA; Choi MS
Mol Nutr Food Res; 2011 Sep; 55 Suppl 2():S173-85. PubMed ID: 21618427
[TBL] [Abstract][Full Text] [Related]
32. FABP4-Cre Mediated Expression of Constitutively Active ChREBP Protects Against Obesity, Fatty Liver, and Insulin Resistance.
Nuotio-Antar AM; Poungvarin N; Li M; Schupp M; Mohammad M; Gerard S; Zou F; Chan L
Endocrinology; 2015 Nov; 156(11):4020-32. PubMed ID: 26248218
[TBL] [Abstract][Full Text] [Related]
33. Saskatoon berry powder reduces hepatic steatosis and insulin resistance in high fat-high sucrose diet-induced obese mice.
Zhao R; Xiang B; Dolinsky VW; Xia M; Shen GX
J Nutr Biochem; 2021 Sep; 95():108778. PubMed ID: 34004342
[TBL] [Abstract][Full Text] [Related]
34. Chlorogenic acid improves high fat diet-induced hepatic steatosis and insulin resistance in mice.
Ma Y; Gao M; Liu D
Pharm Res; 2015 Apr; 32(4):1200-9. PubMed ID: 25248334
[TBL] [Abstract][Full Text] [Related]
35. Integrin α1-null mice exhibit improved fatty liver when fed a high fat diet despite severe hepatic insulin resistance.
Williams AS; Kang L; Zheng J; Grueter C; Bracy DP; James FD; Pozzi A; Wasserman DH
J Biol Chem; 2015 Mar; 290(10):6546-57. PubMed ID: 25593319
[TBL] [Abstract][Full Text] [Related]
36. CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance.
Brown JM; Betters JL; Lord C; Ma Y; Han X; Yang K; Alger HM; Melchior J; Sawyer J; Shah R; Wilson MD; Liu X; Graham MJ; Lee R; Crooke R; Shulman GI; Xue B; Shi H; Yu L
J Lipid Res; 2010 Nov; 51(11):3306-15. PubMed ID: 20802159
[TBL] [Abstract][Full Text] [Related]
37. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase.
Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ
Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686
[TBL] [Abstract][Full Text] [Related]
38. miR-188 promotes liver steatosis and insulin resistance via the autophagy pathway.
Liu Y; Zhou X; Xiao Y; Li C; Huang Y; Guo Q; Su T; Fu L; Luo L
J Endocrinol; 2020 Jun; 245(3):411-423. PubMed ID: 32252024
[TBL] [Abstract][Full Text] [Related]
39. Liver Perilipin 5 Expression Worsens Hepatosteatosis But Not Insulin Resistance in High Fat-Fed Mice.
Trevino MB; Mazur-Hart D; Machida Y; King T; Nadler J; Galkina EV; Poddar A; Dutta S; Imai Y
Mol Endocrinol; 2015 Oct; 29(10):1414-25. PubMed ID: 26296152
[TBL] [Abstract][Full Text] [Related]
40. Ceramide synthase 6 (CerS6) is upregulated in alcohol-associated liver disease and exhibits sex-based differences in the regulation of energy homeostasis and lipid droplet accumulation.
Jeon S; Scorletti E; Dempsey J; Buyco D; Lin C; Saiman Y; Bayen S; Harkin J; Martin J; Hooks R; Ogretmen B; Argemi J; Melo L; Bataller R; Carr RM
Mol Metab; 2023 Dec; 78():101804. PubMed ID: 37714377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
